Akova B, et al
Liv Hospitals guidelines are based on the latest research and clinical evidence
It ensures that any changes in performance or metabolic markers are directly attributable to the supplementation protocol rather than extraneous factors
Cluster 2 comprised constipation, dehydration, headache, diarrhea, dizziness, hypoglycemia, sweating, and jaundice
Your body needs melatonin to initiate and sustain sleep
When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities